FRANCINA WHITLEY: Open Payments
NPI 1467010298 · MISSION, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$286 in 13 payments from 6 companies in 2025. Trend: 2023 $314 · 2024 $0 · 2025 $286
Food & beverage: $286
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company | 7 | $142 |
| Gilead Sciences, Inc. | 2 | $45 |
| Theratechnologies Inc. | 1 | $32 |
| Napo Pharmaceuticals Inc | 1 | $30 |
| Melinta Therapeutics, LLC | 1 | $20 |
| Lilly USA, LLC | 1 | $16 |
Products named: CABENUVA, DOVATO, EGRIFTA, Mytesi, Yeztugo, Rezzayo, APRETUDE, MOUNJARO.
Industry payments across KS — which companies pay providers there.
